|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2002-4-3
|
|
pubmed:abstractText |
Alpha-4 integrins facilitate leucocyte migration across vascular endothelium.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
0269-2813
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
16
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
699-705
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:11929387-Antibodies, Monoclonal,
pubmed-meshheading:11929387-Antigens, CD,
pubmed-meshheading:11929387-Colitis, Ulcerative,
pubmed-meshheading:11929387-Female,
pubmed-meshheading:11929387-Half-Life,
pubmed-meshheading:11929387-Humans,
pubmed-meshheading:11929387-Infusions, Intravenous,
pubmed-meshheading:11929387-Integrin alpha4,
pubmed-meshheading:11929387-Male,
pubmed-meshheading:11929387-Pilot Projects,
pubmed-meshheading:11929387-Quality of Life,
pubmed-meshheading:11929387-Questionnaires,
pubmed-meshheading:11929387-Sigmoidoscopy,
pubmed-meshheading:11929387-Treatment Outcome
|
|
pubmed:year |
2002
|
|
pubmed:articleTitle |
A pilot study of treatment of active ulcerative colitis with natalizumab, a humanized monoclonal antibody to alpha-4 integrin.
|
|
pubmed:affiliation |
Centre for Gastroenterology, Royal Free and University College Medical School, London, UK. fionagorgon@ownhomeline.freeserve.co.uk
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, Non-U.S. Gov't
|
